Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Paredes

Showing results (231-240 of 309) with videos related to

Pageof 31
Sort By:
The Lancet. Microbe|June 10, 2024
Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort studyIgor Moraes-Cardoso, Susana Benet, Julieta Carabelli, et al.
Journal of the International AIDS Society|November 14, 2014
Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST studyFederico Garcia, Eva Poveda, Maria Jesús Pérez-Elías, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 20, 2026
Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVIDLourdes Mateu, Louise L Hansen, Joao Pedro Carmezim, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2021
Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European CohortAnnegret Pelchen-Matthews, Álvaro H Borges, Joanne Reekie, et al.
Plos One|January 13, 2016
A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep PyrosequencingElizabeth P St John, Birgitte B Simen, Gregory S Turenchalk, et al.
Cell Reports. Medicine|March 2, 2022
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infectionEdwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.
Viruses|June 27, 2025
Identification of Clinical and Genomic Features Associated with SARS-CoV-2 ReinfectionsFrancisco Muñoz-López, Antoni E Bordoy, Francesc Català-Moll, et al.
Plos One|July 29, 2017
Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretationRoger Paredes, Philip L Tzou, Gert van Zyl, et al.
Plos One|January 26, 2016
Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAARTJose Manuel Vazquez-Guillen, Gerardo C Palacios-Saucedo, Lydia G Rivera-Morales, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 31, 2026
Systematic echocardiography in patients with hematological malignancies and Gram-positive bacteremia, is it really needed?Claudia Biosca, Mercè Aren-Jubany, Maria Dolores Quesada, et al.
Pageof 31

Showing results (231-240 of 309) with videos related to

Sort By:
Pageof 31
The Lancet. Microbe|June 10, 2024
Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort studyIgor Moraes-Cardoso, Susana Benet, Julieta Carabelli, et al.
Journal of the International AIDS Society|November 14, 2014
Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST studyFederico Garcia, Eva Poveda, Maria Jesús Pérez-Elías, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 20, 2026
Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVIDLourdes Mateu, Louise L Hansen, Joao Pedro Carmezim, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2021
Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European CohortAnnegret Pelchen-Matthews, Álvaro H Borges, Joanne Reekie, et al.
Plos One|January 13, 2016
A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep PyrosequencingElizabeth P St John, Birgitte B Simen, Gregory S Turenchalk, et al.
Cell Reports. Medicine|March 2, 2022
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infectionEdwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.
Viruses|June 27, 2025
Identification of Clinical and Genomic Features Associated with SARS-CoV-2 ReinfectionsFrancisco Muñoz-López, Antoni E Bordoy, Francesc Català-Moll, et al.
Plos One|July 29, 2017
Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretationRoger Paredes, Philip L Tzou, Gert van Zyl, et al.
Plos One|January 26, 2016
Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAARTJose Manuel Vazquez-Guillen, Gerardo C Palacios-Saucedo, Lydia G Rivera-Morales, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 31, 2026
Systematic echocardiography in patients with hematological malignancies and Gram-positive bacteremia, is it really needed?Claudia Biosca, Mercè Aren-Jubany, Maria Dolores Quesada, et al.
Pageof 31